535
edits
Changes
no edit summary
!LOD*** (H1N1)
|-
|SanquinAbbott|Binax Now Influenza A & B Card 2|Yes|DIGIVAL|70-89%<ref name=”[27]”"Arti18">MabTrack level adalimumab (2018)Sensitivity and Specificity Abbott RIDT, Abbott, https://www. Leaflet ''MabTrack level adalimumab''globalpointofcare. Sanquinabbott/nl/product-details/binaxnow-influenza-a-and-b.html</ref>|M2910|MabTrack level adalimumab|5 μL|1–30 µg/mL|1:19990-99%<br /ref name="Arti18">1Sensitivity and Specificity Abbott RIDT, Abbott, https:1499//www.globalpointofcare.abbott/nl/product-details/binaxnow-influenza-a-and-b.html<br /ref>1:1999|Total CV < 15%<br /> Inter-assay: CV < 15.4%NPS, NS direct|2 hours 10 min.n/a
|-
|apDia<ref name=”[28]”>apDia Adalimumab ELISA (2016). Leaflet ''apDia Adalimumab ELISA.'' apDia.</ref>
